Literature DB >> 18275992

Anabolic-androgenic steroid dependence? Insights from animals and humans.

Ruth I Wood1.   

Abstract

Anabolic-androgenic steroids (AAS) are drugs of abuse. They are taken in large quantities by athletes and others to increase performance, with negative health consequences. As a result, in 1991 testosterone and related AAS were declared controlled substances. However, the relative abuse and dependence liability of AAS have not been fully characterized. In humans, it is difficult to separate the direct psychoactive effects of AAS from reinforcement due to their systemic anabolic effects. However, using conditioned place preference and self-administration, studies in animals have demonstrated that AAS are reinforcing in a context where athletic performance is irrelevant. Furthermore, AAS share brain sites of action and neurotransmitter systems in common with other drugs of abuse. In particular, recent evidence links AAS with opioids. In humans, AAS abuse is associated with prescription opioid use. In animals, AAS overdose produces symptoms resembling opioid overdose, and AAS modify the activity of the endogenous opioid system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18275992      PMCID: PMC2585375          DOI: 10.1016/j.yfrne.2007.12.002

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  149 in total

1.  Rewarding properties of testosterone in intact male mice: a pilot study.

Authors:  M T Arnedo; A Salvador; S Martinez-Sanchis; E Gonzalez-Bono
Journal:  Pharmacol Biochem Behav       Date:  2000-02       Impact factor: 3.533

2.  Increased premature mortality of competitive powerlifters suspected to have used anabolic agents.

Authors:  M Pärssinen; U Kujala; E Vartiainen; S Sarna; T Seppälä
Journal:  Int J Sports Med       Date:  2000-04       Impact factor: 3.118

3.  Role of dopamine receptor subtypes in the acquisition of a testosterone conditioned place preference in rats.

Authors:  J P Schroeder; M G Packard
Journal:  Neurosci Lett       Date:  2000-03-17       Impact factor: 3.046

4.  Anabolic-androgenic steroid dependence.

Authors:  K J Brower; F C Blow; T P Beresford; C Fuelling
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

5.  Cause and manner of death among users of anabolic androgenic steroids.

Authors:  I Thiblin; O Lindquist; J Rajs
Journal:  J Forensic Sci       Date:  2000-01       Impact factor: 1.832

6.  Violent crime possibly associated with anabolic steroid use.

Authors:  G N Conacher; D G Workman
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

7.  Anabolic androgenic steroids and suicide.

Authors:  K J Brower; F C Blow; G A Eliopulos; T P Beresford
Journal:  Am J Psychiatry       Date:  1989-08       Impact factor: 18.112

8.  Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial.

Authors:  H G Pope; E M Kouri; J I Hudson
Journal:  Arch Gen Psychiatry       Date:  2000-02

9.  Anabolic steroids induce region- and subunit-specific rapid modulation of GABA(A) receptor-mediated currents in the rat forebrain.

Authors:  J C Jorge-Rivera; K L McIntyre; L P Henderson
Journal:  J Neurophysiol       Date:  2000-06       Impact factor: 2.714

10.  Heroin self-administration by rats: influence of dose and physical dependence.

Authors:  S Dai; W A Corrigall; K M Coen; H Kalant
Journal:  Pharmacol Biochem Behav       Date:  1989-04       Impact factor: 3.533

View more
  44 in total

Review 1.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 2.  Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.

Authors:  Laura A Berner; Tiffany A Brown; Jason M Lavender; Emily Lopez; Christina E Wierenga; Walter H Kaye
Journal:  Mol Cell Endocrinol       Date:  2018-11-02       Impact factor: 4.102

3.  Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2009-04-01       Impact factor: 4.492

4.  Risk profile of male college athletes who use performance-enhancing substances.

Authors:  Jennifer F Buckman; David A Yusko; Helene R White; Robert J Pandina
Journal:  J Stud Alcohol Drugs       Date:  2009-11       Impact factor: 2.582

5.  Development and validation of the appearance and performance enhancing drug use schedule.

Authors:  Tom Hildebrandt; James W Langenbucher; Justine Karmin Lai; Katharine L Loeb; Eric Hollander
Journal:  Addict Behav       Date:  2011-05-11       Impact factor: 3.913

Review 6.  Testosterone and sport: current perspectives.

Authors:  Ruth I Wood; Steven J Stanton
Journal:  Horm Behav       Date:  2011-10-01       Impact factor: 3.587

7.  Iatrogenic dependence of anabolic-androgenic steroid in an Indian non-athletic woman.

Authors:  Adarsh Tripathi; Bheemsain Tekkalaki; Shashwat Saxena; Himanshu Dandu
Journal:  BMJ Case Rep       Date:  2014-02-06

Review 8.  Intracranial self-stimulation to evaluate abuse potential of drugs.

Authors:  S Stevens Negus; Laurence L Miller
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 9.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

10.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.